Use of melagatran or a pharmaceutically acceptable derivative thereof, method of treating an ischemic disorder in a patient having, or at risk for, nonvalvular atrial fibrillation and pharmaceutical formulation

摘要

"USE OF MELAGATRAN OR ITS PHARMACEUTICALLY ACCEPTABLE DERIVATIVE, METHOD OF TREATMENT OF AN ISCHEMICAL DISTURBANCE IN A PATIENT HAVING, OR AT THE RISK OF HAVING, NON-VALVULAR ATRIAL FIBRILATION, AND" FORMULATION. According to the invention, the use of melagatran or a pharmaceutically acceptable derivative thereof is provided for the manufacture of a medicament for the treatment of ischemic disorders in patients having or at risk of having nonvalvular atrial fibrillation.